rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Telix Pharmaceuticals Limited - American Depositary Shares

TLX · Nasdaq

Health CareBiotechnologyJust started moving

TLX stood above a rising 150-day average in 21 of the last 52 weekly readings, including each of the last 16 weeks. It is 0.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
16 in a row
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$2.0M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
60 (+24)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 21 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Darren Charlton SmithGroup Chief Financial Officerbought2,071at $9.667 Sep 2026filed 14 Sep 2026
Christian BehrenbruchMD & Group CEObought33,435at $14.8729 Apr 2026filed 6 May 2026
Christian BehrenbruchMD & Group CEObought34,500at $14.4828 Apr 2026filed 6 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders60+24 on the quarter
New · exited25 · 2
Reported value$36.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCreduced · filed 13 Aug 2026561,206$6.5M-3,551−0.6%
LAZARD ASSET MANAGEMENT LLCreduced · filed 14 Aug 2026284,207$3.3M-5,710−2.0%
PORTLAND INVESTMENT COUNSEL INC.unchanged · filed 13 Aug 2026266,200$3.1M00.0%
Private Advisor Group, LLCadded · filed 27 Jul 2026197,250$2.3M+22,835+13.1%
MARSHALL WACE, LLPnew · filed 13 Aug 2026189,188$2.2M+189,188
MORGAN STANLEYadded · filed 13 Aug 2026165,978$1.9M+49,538+42.5%
Integrated Wealth Concepts LLCunchanged · filed 12 Aug 2026164,397$1.9M00.0%
Hennion & Walsh Asset Management, Inc.new · filed 8 Jul 2026150,138$1.7M+150,138
UBS Group AGadded · filed 13 Aug 2026134,698$1.6M+102,398+317.0%
BLAIR WILLIAM & COnew · filed 11 Aug 2026122,985$1.4M+122,985
30 Jun 2024 – 30 Jun 2026
23058Jun 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Darren Charlton Smith Company insiderGroup Chief Financial Officer · last 7 Sep 20261 · 0
Christian Behrenbruch Company insiderMD & Group CEO · last 29 Apr 20262 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20251.2%

Analyst forecasts

No analyst forecasts yet.